Atlas Trials

A Phase 1 Study of EXT608 in Healthy Adults

Clinical trial NCT05408663 · COMPLETED

Trial details

NCT number
NCT05408663
Sponsor
Extend Biosciences Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Safety Issues
Start date
2022-07-21
Primary completion
2023-06-13
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.